
Veracyte Inc
NASDAQ:VCYT

Intrinsic Value
The intrinsic value of one
VCYT
stock under the Base Case scenario is
21.13
USD.
Compared to the current market price of 30.6 USD,
Veracyte Inc
is
Overvalued by 31%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Veracyte Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Veracyte Inc
Balance Sheet Decomposition
Veracyte Inc
Current Assets | 372.3m |
Cash & Short-Term Investments | 289.4m |
Receivables | 46.5m |
Other Current Assets | 36.3m |
Non-Current Assets | 927.8m |
PP&E | 71.1m |
Intangibles | 848.1m |
Other Non-Current Assets | 8.5m |
Free Cash Flow Analysis
Veracyte Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Veracyte Inc
Revenue
|
445.8m
USD
|
Cost of Revenue
|
-147.6m
USD
|
Gross Profit
|
298.1m
USD
|
Operating Expenses
|
-278.6m
USD
|
Operating Income
|
19.5m
USD
|
Other Expenses
|
4.6m
USD
|
Net Income
|
24.1m
USD
|
VCYT Profitability Score
Profitability Due Diligence
Veracyte Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Score
Veracyte Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
VCYT Solvency Score
Solvency Due Diligence
Veracyte Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Score
Veracyte Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VCYT Price Targets Summary
Veracyte Inc
According to Wall Street analysts, the average 1-year price target for
VCYT
is 46.27 USD
with a low forecast of 29.29 USD and a high forecast of 56.7 USD.
Dividends
Current shareholder yield for VCYT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VCYT
stock under the Base Case scenario is
21.13
USD.
Compared to the current market price of 30.6 USD,
Veracyte Inc
is
Overvalued by 31%.